Form D · Biotechnology

MicrobeDx, Inc.

Pacific Palisades, CA · CIK 0001701959

Offering snapshot reported Oct 20, 2021 · SEC filing

Reported sold
$507K
Offering amount: $507K
Investors reported
2
Form D · investor count
Minimum accepted
$0
Reported outside-investor minimum
First sale
Oct 7, 2021
As reported in this filing

What changed?

Latest filing versus its linked predecessor, where available.

No comparable changes in the displayed metrics.

Filing history

Scroll to see all columns →

FiledFiling typeReported soldChange vs linked filingInvestorsSource
Oct 20, 2021Initial$507,020No comparison2SEC filing
Jan 8, 2021Initial$300,000No comparison5SEC filing
Apr 15, 2019Initial$3,006,900No comparison11SEC filing
Jan 24, 2018Initial$2,500,000No comparison14SEC filing
May 5, 2017Initial$400,000No comparison6SEC filing

Offering details

Securities
Equity
Exemptions
06b
Duration over one year
No
Business combination
No
Sales commissions
$0
Finders' fees
$0
Form D file number
021-417766

Source: Form D, filed Oct 20, 2021. Minimum accepted may differ from a standard advertised minimum.

Fund connections

No confirmed ADV fund connection is available for this issuer.

People & organizations

Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.

People and organizations reported in Form D filings
NameReported role
Todd Bartos Director
Chuck Blevin Executive
Bernard Churchill Director
Michael Churchill Director, Executive
David Haake Director, Executive
Colin Halford Director
John Hyshka Director, Executive
Richard Janeczko Director, Executive
James Ratner Director
Maziar Zarrehparvar Executive

Issuer details

Industry: Biotechnology (See others in industry)

Address:
17866 Tramonto Drive
Pacific Palisades, CA, 90272